Form 4 for BDX Becton Dickinson
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001628280-25-054349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-11-26 | BDX | Feld Michael | EVP, CRO, Pres. Life Sciences | A - Grant | $0.00 | +8,829 | 17.1K | +107% | $0 | |
| 2025-12-01 | 2025-11-26 | BDX | Feld Michael | EVP, CRO, Pres. Life Sciences | F - Tax | $0.00 | -419 | 16.7K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-26 | A | A | 8,829 | $0.00 | 17,074 | D | — | — | (F1) Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
| 2 | Common | Common Stock | 2025-11-26 | F | D | 419 | $0.00 | 16,655 | D | — | — | (F2) Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. |